| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.087 | 0.05 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.081 | 0.06 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |